ArticleThe Lancet. Infectious diseases2026

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.

Nadine Rouphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.